Golden Eye

Golden Eye is an ocular anti‑infective product whose active ingredient is dibrompropamidine isetionate. The formulation’s strength and dosage form are not disclosed, but it is intended for eye application. As a diamidine antiseptic, it works by disrupting microbial cell membranes and interfering with DNA function, helping to eliminate susceptible bacteria that cause eye infections. It is marketed within the European Union and is classified as an antiseptic for eye use.

Golden Eye is indicated for the treatment of certain superficial ocular infections where an antiseptic effect is desired.

- Bacterial conjunctivitis, including mild to moderate cases caused by susceptible Gram‑positive or Gram‑negative organisms. - Blepharitis where bacterial colonisation contributes to eyelid inflammation. - Minor corneal epithelial defects or abrasions that are at risk of bacterial infection. - Prophylactic use after minor ocular surgery or invasive diagnostic procedures to reduce postoperative infection risk. - Trachoma and other endemic bacterial eye diseases where a diamidine antiseptic is part of the therapeutic regimen. - Superficial ocular surface infections such as keratitis limited to the epithelium when caused by susceptible bacteria.

Adverse reactions to Golden Eye are generally uncommon, but they can be categorized by frequency and severity.

Common: - Transient eye irritation or burning sensation upon instillation. - Mild redness of the conjunctiva. - Temporary blurred vision that resolves shortly after use. - Slight tearing or increased lacrimation. - Mild itching of the eyelid margin. - Temporary photophobia. - Mild foreign body sensation. - Mild swelling of the conjunctival tissue.

Serious: - Allergic contact dermatitis of the eyelid skin. - Severe ocular inflammation or uveitis. - Persistent corneal epithelial defect. - Vision loss not attributable to the underlying infection. - Corneal ulceration or stromal involvement. - Systemic allergic reaction such as rash or facial swelling. - Endophthalmitis if infection progresses despite therapy.

When using Golden Eye, certain precautions should be observed to ensure safety and effectiveness.

- Do not use if you have a known hypersensitivity to dibrompropamidine or any component of the product. - Avoid contact lens wear until the medication has been fully cleared from the eye surface. - Discontinue use and seek medical advice if symptoms worsen or fail to improve within the expected time frame. - Keep the eye drop container tightly closed and store it at room temperature, protected from light. - Do not share the product with other individuals to prevent cross‑contamination. - Use only the prescribed duration; prolonged use may disrupt normal ocular flora.

Golden Eye may interact with other ophthalmic agents; consider the following guidance.

Avoid: - Concurrent use with other antiseptic eye drops containing similar diamidine compounds, which may increase irritation. - Simultaneous administration of topical corticosteroids, as they may mask signs of infection. - Avoid using with eye drops that contain preservatives known to cause allergic reactions, as combined exposure may increase risk.

Use with caution: - Co‑administration with contact lens solutions; ensure thorough rinsing of lenses before and after use. - Use alongside systemic antibiotics only if directed by a healthcare professional, to avoid overlapping antimicrobial effects. - Combining with ocular anesthetic drops may enhance local discomfort. - When using with anti‑glaucoma medications, monitor intra‑ocular pressure as the antiseptic may cause transient changes. - Use with caution when combined with other ocular anti‑infectives to avoid additive toxicity.